West Pharmaceutical Services (WST, $365.88) Enters Weekly Bullish Trend: Expect Uptrend Continuation
The integration of AI in the stock market has opened up new opportunities for traders and investors to make well-informed decisions. Specifically, in the case of West Pharmaceutical Services (WST).
Tickeron's Swing Trader: Hi-tech, Consumer and Financial Sectors (Diversified) bot, has been a top performer in their robot factory. Traders can access this bot through the Tickeron website and gain valuable insights into potential trading opportunities. By utilizing AI and technical analysis, the bot provides recommendations for buying and selling AI stock.
Investors in West Pharmaceutical Services (WST) have a lot to look forward to in the coming week, according to A.I.dvisor's predictions. The stock is predicted to grow by 2% to $373.2 or more within the next week, indicating a strong bullish trend.
WST has been on a winning streak, with a week-long uptrend that is expected to continue. The odds of an uptrend continuation are 74%, making this a promising investment opportunity for investors who are looking for short-term gains.
However, it's important to keep an eye on WST's recent trend. The stock has been in a downward trend, falling for three consecutive days on April 18, 2023. This is viewed as a bearish sign, and investors should be cautious about future declines.
A.I.dvisor's data shows that when WST declined for three days in the past, in 125 out of 255 cases, the price declined further within the following month. This means that the odds of a continued downward trend are 49%.
While the bullish trend for WST is promising, investors should consider both short-term and long-term investment strategies. Investing in a company with a winning streak can be an excellent way to earn quick profits, but it's also important to consider the long-term implications of the stock's recent trend.
WST is predicted to continue its uptrend for the next week, making it an attractive option for investors looking for short-term gains. However, investors should also be aware of the recent downward trend and take a cautious approach to their investments. By carefully analyzing the data and considering both short-term and long-term investment strategies, investors can take advantage of the bullish trend while managing their risk effectively.
Our platform utilizes the power of AI to provide you with valuable insights and analysis, helping you make informed decisions when it comes to trading and investing. Don't miss out on this opportunity to take your stock market game to the next level. Register with us now and start making money! If you're interested in stocks and want to stay ahead of the game, consider registering with us, click here.
WST's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for WST turned positive on March 04, 2025. Looking at past instances where WST's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where WST's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WST advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on WST as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 50-day moving average for WST moved below the 200-day moving average on February 25, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.060) is normal, around the industry mean (23.715). P/E Ratio (50.246) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (7.006) is also within normal values, averaging (5.667). Dividend Yield (0.002) settles around the average of (0.018) among similar stocks. P/S Ratio (10.111) is also within normal values, averaging (41.612).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a manufacturer of pharmaceuticals, biologics, vaccines and consumer healthcare products
Industry MedicalSpecialties